EANS-News: Marseille-Kliniken AG achieves strong earnings improvement

--------------------------------------------------------------------------------
Corporate news transmitted by euro adhoc. The issuer/originator is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Financial Figures/Balance Sheet/Preliminary half yearly results

Subtitle: - EBIT improved by more than 50 percent to EUR 5.0 million
- Revenues increased slightly to EUR 96.4 million - Focusing on
operational business clearly proves to be successful - Earnings
guidance of EUR 10.0 million for complete financial year confirmed

Hamburg, Germany (euro adhoc) - 20 January 2012 - Marseille-Kliniken
AG could improve its profitability in the first half of the 2011/2012
financial year (1 July through 31 December 2011) according to
preliminary figures. EBIT rose by 56 percent to EUR 5.0 million
(previous year: EUR 3.2 million). The occupancy rate rose to 88.6
percent after an average of 87.1 percent in the past financial year.
Revenues increased slightly to EUR 96.4 million (previous year: EUR
95.2 million). "This further improvement of the profitability shows
that our focusing on the operational business could be successfully
realized. We expect this positive development to continue also in the
whole financial year", says Michael Thanheiser, chairman of
Marseille-Kliniken AG.

In the previous financial year and in the first six months of the
2011/2012 financial year, Marseille-Kliniken AG reinforced its focus
towards the core competencies in inpatient and outpatient care for
the elderly, strengthened its quality leadership, and introduced a
new, decentralised management structure. Moreover a programme carried
out to optimise costs also played a role in supporting the company's
economic recovery. Marseille-Kliniken AG operates a total of 60 care
facilities across Germany, with a sales capacity of 7,940 beds on 31
December 2011.

Against the backdrop of the half yearly results, Marseille-Kliniken
AG confirms its forecast for the 2011/2012 financial year, which
calls for a slight revenue increase and Group EBIT of EUR 10.0
million, well above the previous year's level. Most important aspect
will remain the focusing on the core competency in the nursing care
business. Marseille-Kliniken AG will release the full results for the
first half of the 2011/2012 financial year on 8 February 2012. The
corresponding half yearly report will then be made available to the
public on the company's website at www.marseille-kliniken.com.

Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.marseille-kliniken.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

company: Marseille-Kliniken AG
Alte Jakobstraße 79/80
D-10179 Berlin
phone: +49 (0)30 246 32-400
FAX: +49 (0)30 246 32-401
mail: info@marseille-kliniken.de
WWW: http://www.marseille-kliniken.de
sector: Pharmaceuticals
ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
Hamburg, regulated dealing/prime standard: Frankfurt
language: English